Bio Industry

UNeMed, a member of Bio Nebraska, is accepting applications for its 2022 Technology Transfer Boot Camp. Read more

Bristol Myers Squibb, a member of Bio Nebraska, announced last week that the FDA approved Camzyos™ for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (obstructive HCM) to improve functional capacity and symptoms. Read more

Join NIAMRRE in Lincoln, Nebraska for their 2022 Annual Conference, May 16-18, 2022. Read more

Merck Animal Health, a member of Bio Nebraska, recently introduced the Herd Health Manager and Feedlot Diseases App to help caretakers manage important cattle health information. Read more

Thyreos, a member of Bio Nebraska, has been awarded an SBIR grant to develop a new vaccine to protect against Infectious Bovine Rhinotracheitis (IBR), a disease that causes respiratory illness in cattle.  Read more

Kirk Zeller, founder of the Silicon Prairie Center and co-founder of Progressive NEURO, won the Excellence in Entrepreneurship award at the University of Nebraska at Kearney’s Light it Up! celebration on April 14. Read more

Shane Farritor, co-founder and chief technology officer of Virtual Incision, is the inaugural winner of the University of Nebraska system’s Faculty IP Innovation and Commercialization Award. Virtual Incision, a member of Bio Nebraska, is working to commercialize miniature surgical robots for minimally invasive procedures. Read more

Novartis, a member of Bio Nebraska, announced that the FDA approved Pluvicto, a targeted radioligand therapy (RLT) for eligible patients with metastatic castration-resistant prostate cancer. Pluvicto is expected to be available to physicians and patients within weeks. Read more